CCK-8 (WST-8) Colorimetric Cell Viability Assay: Principles, Experimental Design, and Typical Applications

CCK-8 (Cell Counting Kit-8) is a colorimetric cell-viability assay system based on the water-soluble tetrazolium salt WST-8. It is widely used for cell proliferation, cytotoxicity, and drug-sensitivity evaluation. A key advantage is that the reaction product is a water-soluble formazan, enabling direct absorbance measurement near 450 nm without a solubilization step. This makes the workflow convenient and relatively sensitive, and it can support time-course monitoring in the same well under appropriate conditions. This guide summarizes the assay principle, typical kit composition and storage, experimental design and operating notes, data processing, representative applications, and a structured troubleshooting strategy to support reusable and maintainable workflows in research and quality assessment.

Keywords: CCK-8; WST-8; cell viability; cell proliferation; cytotoxicity; drug sensitivity

I. CCK-8 Assay Overview

CCK-8 is commonly used to quantify relative viability and proliferation changes of adherent or suspension cells under defined culture conditions and treatment factors (e.g., drugs, material extracts, genetic perturbations, inflammatory stimuli). The readout is an optical density (OD) signal. Within an appropriate window of cell density and incubation time, OD is approximately linear with the number of viable cells (or overall metabolic activity). Importantly, CCK-8 primarily reflects metabolic reducing capacity rather than a direct cell count. When a treatment substantially reprograms cellular metabolism without inducing cell death, interpretation should be supported by orthogonal evidence such as morphology, apoptosis/necrosis assays, colony formation, or direct counting.

II. Assay Principle and Signal Origin

2.1 WST-8 Reduction and Water-Soluble Formazan Formation

WST-8 is the key chromogenic substrate in CCK-8. Multiple intracellular dehydrogenase systems and reducing equivalents (e.g., NADH/NADPH) can transfer electrons to WST-8, reducing it to an orange, water-soluble formazan product. The product has a characteristic absorption in the visible region; absorbance is typically measured at 450 nm to represent signal intensity. Because the formazan is water-soluble, the workflow avoids the formazan dissolution step required by MTT-type assays, reducing handling variability and improving throughput.

2.2 Boundary Conditions: How the Signal Relates to Cell State

Factors that influence the WST-8 reduction rate include cell number, cell type and metabolic level, medium composition, and the redox characteristics of drugs or samples. Accordingly, CCK-8 is best suited for relative comparisons among treatment groups within the same cell system. If absolute comparisons across cell lines or culture conditions are required, establish a standard curve and design controls accordingly.

III. Kit Components, Storage, and Pre-use Preparation

3.1 Typical Kit Components

A typical CCK-8 kit includes:

① CCK-8 working solution

An ready-to-use solution containing WST-8 and an electron mediator system.

② Instructions and recommended parameters

Manufacturer guidance for recommended volumes, incubation windows, and readout settings.

3.2 Storage Conditions and Stability Notes

Store protected from light and at the temperature specified by the kit instructions (commonly 2–8 °C or −20 °C, depending on the formulation). Avoid repeated freeze–thaw cycles and prolonged exposure at room temperature. During use, minimize strong-light exposure and promptly reseal and return reagents to storage to reduce spontaneous substrate degradation and background elevation.

3.3 Key Preparation Items Before the Experiment

Before running the assay, ensure the following are defined and standardized:

① Select an appropriate plate format (96-well plates are most common) and confirm that the microplate reader supports measurement at 450 nm.

② Determine the linear range for cell seeding density and incubation time; confirm by a pilot experiment if needed.

③ Plan controls: a blank (medium + CCK-8, no cells), a negative control (cells + vehicle), a positive control (a known cytotoxic treatment), and a sample background control (sample + medium + CCK-8, no cells) for colored or strongly absorbing/redox-active samples.

IV. Experimental Design and Operating Notes

4.1 Recommended Workflow (96-Well Plate Example)

A typical workflow is as follows (keep total volumes and vehicle concentrations consistent across wells):

① Seed cells: seed an appropriate number of cells into a 96-well plate, using equal medium volume per well (a typical working volume is 100 μL/well), with ≥3 technical replicates.

② Allow attachment and recovery: adherent cells are typically pre-cultured to stable attachment and logarithmic growth; suspension cells may be equilibrated briefly after seeding.

③ Apply treatments: add drugs/samples/conditions, maintaining equal total volume and equal solvent concentration (e.g., DMSO) across wells.

④ Add CCK-8: add CCK-8 working solution at the recommended ratio (commonly 10 μL into 100 μL medium, ~10% v/v). Mix gently and avoid bubbles.

⑤ Incubate: incubate at 37 °C protected from light; typical incubation time is 0.5–4 h, optimized for linearity and signal-to-noise.

⑥ Read: measure absorbance at 450 nm. If supported, a reference wavelength (e.g., near 650 nm) can help correct nonspecific scattering and plate effects, per instrument and lab practice.

4.2 Optimizing the Linear Window: Seeding Density and Incubation Time

Key considerations include:

① Too few cells: weak signal and higher variability.

② Too many cells or overly long incubation: the assay may enter a plateau due to substrate depletion or metabolic saturation, and OD may no longer increase linearly.

③ Recommendation: run a matrix of seeding-density gradients (e.g., 0.5×10^3 to 2×10^4 cells/well, adjusted to cell size and growth rate) and multiple incubation times to define an operable linear window before formal experiments.

4.3 Controlling Sample and Medium Interference

Common interference patterns and controls include:

① Color interference: colored drugs, natural-product extracts, or nanoparticle dispersions may absorb at 450 nm. Include a sample background control and subtract it.

② Redox interference: strongly reducing/antioxidant compounds (e.g., some polyphenols, ascorbate-like compounds, thiols) may directly reduce WST-8 and yield false-positive signals; strong oxidants may also destabilize the system. Include no-cell controls and confirm findings with orthogonal methods.

③ Bubbles and edge effects: bubbles distort the optical path; evaporation in edge wells alters concentrations. Pipette gently, remove bubbles (brief centrifugation if appropriate), and preferentially use inner wells or fill edge wells with PBS/sterile water to buffer evaporation.

V. Data Processing and Interpretation

5.1 Baseline Correction

A common approach is to subtract the blank control:

OD_corrected = OD(sample well) − OD(blank well)

If the sample has substantial background (color or spontaneous reduction), apply an additional correction:

OD_final = [OD(sample well) − OD(blank well)] − [OD(sample background well) − OD(medium-only blank)]

5.2 Relative Viability and Inhibition

Common definitions include:

① Relative viability (%) = OD_final(treated) / OD_final(control) × 100%

② Inhibition (%) = 1 − OD_final(treated) / OD_final(control) × 100%

5.3 Dose–Response and IC50

For drug-sensitivity studies, use a logarithmic concentration series and fit a four-parameter logistic curve to estimate IC50, reporting goodness-of-fit, replicate number, and confidence intervals where available. Ensure that data points fall within the dynamic range; a large fraction of plateau points can make parameter estimates unstable.

VI. Typical Application Scenarios

6.1 Proliferation Curves and Growth Kinetics

By adding CCK-8 at one or multiple time points and reading OD, relative proliferation curves can be constructed to compare growth among treatments or cell lines. For same-well time-course monitoring, evaluate whether repeated exposure affects subsequent culture and keep conditions consistent.

6.2 Drug/Compound Cytotoxicity and Sensitivity Evaluation

CCK-8 is suitable for cytotoxicity screening and dose–response analysis of chemotherapeutics, targeted agents, candidate small molecules, and natural-product components. For compounds with strong reducing capacity or intrinsic absorbance, strict no-cell controls and orthogonal assays (e.g., flow cytometry apoptosis, LDH release, colony formation) are recommended.

6.3 Biomaterial and Extract Cytocompatibility

For material extracts or direct-contact conditions, CCK-8 provides a throughput-friendly screen of viability changes. Such samples may introduce scattering or color artifacts; pair the assay with microscopy readouts (morphology, adhesion/spreading) and characterize extract pH and osmolality to support interpretation.

6.4 Viability Readout After Genetic or Signaling Perturbations

After overexpression, knockdown/knockout, CRISPR editing, or pathway inhibition/activation, CCK-8 can serve as a rapid phenotype readout. When perturbations strongly affect mitochondrial function or glycolysis, CCK-8 signals may reflect metabolic reprogramming rather than cell-number changes; combine with counting, EdU incorporation, or colony formation for robust conclusions.

VII. Troubleshooting

7.1 High Background

Common causes and corrective actions include:

① Excess light exposure or improper storage increases spontaneous background; protect from light and follow storage guidance.

② Reducing components in medium or samples require no-cell controls and baseline subtraction.

③ Overlong incubation or unstable temperature control; shorten incubation and optimize conditions.

7.2 Large Within-Group Variability

Common causes and corrective actions include:

① Pipetting variability: use multichannel pipettes and standardized mixing.

② Bubbles: remove bubbles before reading.

③ Uneven cell distribution: gently mix (e.g., cross-pattern) after seeding to reduce localized aggregation.

7.3 Low Signal or No Apparent Differences

Common causes and corrective actions include:

① Low seeding density or poor cell condition; increase density or optimize culture conditions.

② Insufficient treatment time or inappropriate concentration range; expand gradients and extend exposure time.

③ Incorrect wavelength settings or mismatched plate type; verify instrument parameters and plate optical properties.

VIII. Safety and Compliance Notes

CCK-8 working solutions are typically managed as chemical reagents. Wear gloves and eye protection during handling and avoid ingestion or prolonged skin contact. Waste containing cells and drugs should be collected and inactivated according to institutional biosafety and chemical-safety requirements. For samples of unknown toxicity, operate under appropriate containment (e.g., within a biosafety cabinet or fume hood as required by risk assessment).

IX. Aladdin-Related Products

Catalog No.	Product Name	Grade or Purity
W113061	WST-8	≥98%
W422359	WST-8	10 mM in Water
C266180	Cell Counting Kit-8	--
S707171	Solid instant dissolution Cell Counting Kit-8	--

CCK-8 provides a throughput-friendly, relatively sensitive colorimetric readout based on WST-8 reduction to a water-soluble formazan product. High-quality results depend on defining the linear operating window by pilot testing, implementing a rigorous control system (especially for sample background and redox interference), standardizing pipetting and incubation conditions, and corroborating conclusions with orthogonal assays when mechanisms may affect metabolism independently of cell number.

Aladdin: https://www.aladdinsci.com/